InduPro’s Post

It's getting closer and closer.... Wafa Bouaziz, Greg Dombal and I still have some availability to meet and discuss your global regulatory aspirations and how DLRC Group can support your journey. Search "DLRC" in the Partnering Platform or email [email protected] See you there! #BIO2024 #biotech #regulatoryaffairs #partneringforsuccess

Attending #BIO2024 in San Diego? Let's connect in the BIO One-on-One Partnering system. Click below to send Kronos Health a meeting request in the BIO partnering system! #BIO2024 https://lnkd.in/eQZAhkQb I look forward to seeing you in June! #BIO2024 #lifesciences #innovationinhealthcare #strategicpartnerships #commercialstrategy ___________________________________________ If you are an investor seeking external scouting and portfolio support 📊🤝, or a biotech organization in need of stakeholder engagement, revenue influx, portfolio and commercial strategy 📈, KRONOS HEALTH would like to evaluate a collaboration. Let's explore how I can help drive your goals.

Achieving better bioprocess scaleup doesn't have to be hard. Join our webinar to learn the steps you can take to scale better, faster, and smarter. https://cytiva.link/ytdnq #biopharma #lifesciences

Achieving better bioprocess scaleup doesn't have to be hard. Join our webinar to learn the steps you can take to scale better, faster, and smarter. https://cytiva.link/ytdnq #biopharma #lifesciences

Watch this short video to understand who we are, learn about our success and where Pro Lab is headed in the future! https://lnkd.in/eKNNK_99

Lets discuss AI-driven Regulatory Intelligence. See you at Life Science Reg Intel & Strategy Conference over crab cakes !!!🦀

Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum I wanted to let you know the exciting news that Pro-ficiency has been acquired by Simulations Plus (SLP).   Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development, research, and regulatory submissions. We are excited to join forces with a company that shares our commitment to good science, our passion for leveraging advanced technologies to advance critical research, and our dedication to supporting clients in improving their ROI on drug development and patient care. Each of our companies brings unique strengths to the table, and I am confident that together we will see increased growth and success. Both companies leverage simulation technology to accelerate the performance of Life Science companies from discovery to delivery of new therapeutics. Simluations Plus focuses on quantitative simulation and modeling services. Pro-ficiency leverages experiential simulation to elevate the performance of life science teams. The combination creates a one-of-a-kind simulation platform spanning the drug development continuum. Pro-ficiency has shown exceptional growth since the investment by QHP Capital in February of 2021. This $100M transaction provided exception returns to the QHP LPs and Pro-ficiency founders in a timeline just over the ideal holding window of 36 months. I want to thank our employees and customers for creating and supporting the Pro-ficiency journey. Thanks also to QHP Capital that trusted me with guiding this investment for the firm. I am personally excited to join the Simulations Plus team as President. In the coming days, I will sharing some lessons learned for fellow entrepreneurs. https://lnkd.in/evQe-NVM #Simulations-Plus #Pro-ficiency #Simulation

Computer vision and multimodal space urgently require the collaboration of multiple specialized partners to address complex issues and achieve significant results…

Achieving better bioprocess scaleup doesn't have to be hard. Join our webinar to learn the steps you can take to scale better, faster, and smarter. https://cytiva.link/ytdnq #biopharma #lifesciences

The next Peer Learning and Networking webinar focuses on keys to writing a stronger commercialization plan. Get advice from #Biotech innovators like you by watching the pre-recorded videos and tuning into the live Q&A on June 13. https://lnkd.in/ggFxuEY3